Stocks to watch: VeriFone, CME
VeriFone shares sink after posting quarterly results, and the exchange operator shares climb after declaring a stock split.
VeriFone (PAY) shares sank 10% in premarket trading Friday after the company reported late Thursday a 43% drop in earnings in the first quarter and provided outlook that disappointed investors. The company's earnings fell because of acquisition and restructuring costs. Revenue, however, was strong, climbing 61% to $472 million.
CME Group (CME) on Thursday declared a five-for-one stock split of its common stock in the form of a 400% stock dividend. According to CME's president Terry Duffy, splitting the stock will help the derivatives marketplace attract "a broader, more diverse investor portfolios." Shareholders will receive dividend payment on July 20, 2012.
Bank of America (BAC) and Barclays Bank PLC (BCS) have entered into an agreement with Lehman Brothers Holdings to sell their remaining interest in apartment building owner Archstone for $1.58 billion.
Post Holdings (POST), the maker of Honey Bunches of Oats and Grape-Nuts, reported second quarter net income that was down 64% because of excessive advertisement expenses and as revenue dropped from $259 million to $250.5 million. POST closed Thursday at $28.
Rue21 (RUE) posted impressive first quarter earnings late Thursday. The retailer reported earnings of $11.6 million, up $2 million from last year's quarter. The company also raised fiscal 2012 earnings guidance to $1.76 to $1.81 per share.
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
Puma Biotechnology shares soar after it says it wants to file for marketing approval of an experimental breast cancer drug.
VIDEO ON MSN MONEY
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.